60 results
Page 2 of 3
20-F/A
8g6p3yahv5g0g0uac2
23 Mar 15
Annual report (foreign) (amended)
12:00am
20-F/A
EX-4.37
51a 8kyi1fhjff
23 Mar 15
Annual report (foreign) (amended)
12:00am
20-F/A
EX-4.17
v26w 3s9k
23 Mar 15
Annual report (foreign) (amended)
12:00am
20-F/A
EX-4.38
m01t3ni ea
23 Mar 15
Annual report (foreign) (amended)
12:00am
424B5
0pjkrpufqn
6 Mar 15
Prospectus supplement for primary offering
12:00am
424B5
rmy0fp91b0pa4x vi
5 Mar 15
Prospectus supplement for primary offering
12:00am
6-K
EX-99.3
tphhwfrmxyq2lix0nbx
5 Mar 15
Current report (foreign)
12:00am
424B2
843cxfw2a6 p6eerh
13 Jun 14
Prospectus for primary offering
12:00am
F-3
cmcah4t2h2hvql
30 May 14
Shelf registration (foreign)
12:00am
424B5
a6z5nz6uvtry2
4 Mar 14
Prospectus supplement for primary offering
12:00am
424B5
zs8kymd
3 Mar 14
Prospectus supplement for primary offering
12:00am
6-K
EX-99.3
bwvu61106qtt
3 Mar 14
Current report (foreign)
12:00am
6-K
EX-99
b5tl nzsizm
4 Nov 13
BioLineRx Receives Regulatory Approval to Commence
12:00am
424B3
cwda5c
8 Aug 13
Prospectus supplement
12:00am